The Department of Health (DOH), together with other member agencies of the Inter-Agency Committee on Antimicrobial Resistance (ICAMR), culminated the week-long celebration of the Philippine Antimicrobial Awareness Week (PAAW) highlighting the importance of the One Health approach to combat antimicrobial resistance (AMR) fuelled by the COVID-19 pandemic threat.
Traversing towards the realization of quality primary healthcare through free access to essential medicines in support to the goals of the Universal Health Care in Region 1, Laoag City hosted the 17th Policy Dialogue on Universal Health Care and Access to Medicines through a Patient Forum at Sola Hotel, Laoag City, 18 November 2022.
The Philippine Essential Medical Device List (PEMDL) is a compilation of essential medical devices considered as important or necessary for the preventive, diagnostic, therapeutic, or rehabilitative procedures carried out in government health facilities in accordance with Administrative Order No. 2021-0038 “Framework for Philippine Essential Medical Devices List and Price Reference Index”.
Click the title to know more about the PEMDL
Pursuant to the Government’s thrust towards Universal Health Care (UHC) and in light of the major changes in the pharmaceutical landscape, the Department of Health (DOH), through the Pharmaceutical Division (PD), crafted the Philippine Medicines Policy which would be implemented from the years 2022 to 2030 to mobilize all key players in the pharmaceutical sector to implement evidence-based policies, improve sustainability programs and leverage best practices throughout the pharmaceutical supply chain.
After three long years and five virtual policy dialogues, the Department of Health (DOH), its partner agencies and offices and the patient support groups and civil society organizations finally convened again face to face during the 16th Policy Dialogue on Universal Healthcare and Access to Medicines held on June 9, 2022 at Cocoon Boutique Hotel, Quezon City.
The Department of Health-Pharmaceutical Division (DOH-PD) conducted a face-to-face Program Implementation Review (PIR) and updates on the different programs of the Pharmaceutical Division in Coron Palawan last April 26-28, 2022 after two years of restrictions from the COVID-19 pandemic.
The DOH Pharmaceutical Division expresses its gratitude to the leadership and concern for poor and vulnerable Filipino patients shown by President Rodrigo Duterte with the passage of two landmark Executive Orders which set maximum retail price to 120 high cost medicines.
The Association of Southeast Asian Nations (ASEAN) Member States, comprising Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, and Vietnam, convened in a two-day online workshop to ensure fair prices and effective financing of medicines and health technologies with the aim to fortify health systems and to achieve wider Universal Health Coverage on April 6-7, 2022.
The department of health have adjusted the price of several medicines under Government-Mediated Access Price (GMAP). To know more regarding the changes you can access the full contents here.
The Department of Health (DOH) informed the Bureau of Internal Revenue (BIR) through Commissioner Caesar R. Dulay the revisions to the list of VAT-Exempt Medicines under Republic Act. 11354 or Corporate Recovery and Tax Incentives for Enterprises (CREATE) Act.
Advisory on the Delistment of Piperacillin + Tazobactam Preparations in the Government Mediated Access Price (GMAP) List
Delistment of Piperacillin + Tazobactam Preparations in the Government Mediated Access Price (GMAP) List. Click the link to know more regarding the advisory.
DOH calls for comments on the draft EO on the Imposition of Maximum Retail Price (MRP) and Maximum Wholesale Price (MWP) on Selected Drugs and Medicines Used in the Treatment of COVID-19
The Department of Health enjoins all concerned stakeholders to provide position papers, recommendations and other inputs on the draft Executive Order to impose Maximum Retail Price and Maximum Wholesale Price on COVID-19 Drugs and Medicines
The Department of Health enjoins all concerned stakeholders to provide position papers, recommendations and other inputs on the draft Administrative Order that sets the standards on the implementation of the Antimicrobial Stewardship Program in the primary care setting.
Conduct of the 2022 Antimicrobial Stewardship (AMS) Blended Learning Framework Program for Primary Health Care (PHC) Facilities through Online Platforms
The Department of Health will conduct series of virtual trainings on Antimicrobial Stewardship this August and October 2022.
Telephone Number: 02-8757734 Loc. 253
Address: 4th Floor, Philippine Blood Center, Lung Center Compound, Quezon Avenue, Quezon City
Email Address: email@example.com